Yanai Shlomo
Amneal Pharmaceuticals, Inc. · Director
Yanai Shlomo is listed in filings as Director at Amneal Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 8, 2026, including 6 public disclosures. Recent filings connect the profile to Amneal Pharmaceuticals, Inc. (AMRX) and Philip Morris International Inc (PM). The current snapshot covers public activity from May 8, 2025 to May 8, 2026. Reported amounts are shown as $190.2K to $175.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||